STEPHANIE QUANDT: Open Payments
NPI 1831712264 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,115 in 78 payments from 19 companies in 2025. Trend: 2023 $1,559 · 2024 $1,406 · 2025 $1,115
Food & beverage: $1,115
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 30 | $259 |
| Neurocrine BioSciences, Inc. | 10 | $157 |
| ABBVIE INC. | 17 | $145 |
| Lundbeck LLC | 3 | $93 |
| SK Life Science, Inc. | 3 | $64 |
| Noctrix Health, Inc. | 1 | $54 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $44 |
| Janssen Biotech, Inc. | 1 | $38 |
| Cala Health, Inc. | 1 | $33 |
| Biogen, Inc. | 1 | $28 |
Products named: NURTEC ODT, INGREZZA, UBRELVY, REXULTI, NIDRA, JOURNAVX, QULIPTA, Cala kIQ.
Industry payments across NY — which companies pay providers there.
